Robin Andrulevich
Responsable des Ressources Humaines chez SANA BIOTECHNOLOGY, INC.
Profil
Robin Andrulevich is currently the Director at Washington Biotechnology & Biomedical Association and the Chief People Officer & Executive Vice President at Sana Biotechnology, Inc. In the past, Andrulevich worked as a Director at Acepodia Biotechnologies, Ltd., a Principal at Amazon.com, Inc., and as the Senior Vice President-People at Juno Therapeutics, Inc. Andrulevich completed an undergraduate degree at the University of Connecticut.
Postes actifs de Robin Andrulevich
| Sociétés | Poste | Début |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Responsable des Ressources Humaines | 01/09/2018 |
| Washington Biotechnology & Biomedical Association | Directeur/Membre du Conseil | 01/12/2017 |
Anciens postes connus de Robin Andrulevich
| Sociétés | Poste | Fin |
|---|---|---|
| JUNO THERAPEUTICS INC | Responsable des Ressources Humaines | 01/04/2018 |
Acepodia Biotechnologies, Ltd.
 Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan. | Directeur/Membre du Conseil | - |
| AMAZON.COM, INC. | Corporate Officer/Principal | - |
Formation de Robin Andrulevich
| University of Connecticut | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMAZON.COM, INC. | Retail Trade |
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
| Washington Biotechnology & Biomedical Association | |
Acepodia Biotechnologies, Ltd.
Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan. | Health Technology |
